Bioocus Inobatanidzwa muIGC 2024 kuti Iongorore Kubatana Kutsva uye MaModheru Ebhizinesi muImmuno-Gene uye Cell Therapy
Bioocus inofara kuzivisa kuti iri kutora chikamu mu Musangano wechi8 weImmuno-Gene neCell Therapy (IGC 2024), chiitiko chikuru munyaya dzekudzivirira muviri, kurapwa kwemajini, uye kurapa kwakavakirwa pamasero. Sekambani yemazuva ano ye biotechnology yakatarisana nekusimudzira kurapa kwekudzivirira muviri, Bioocus ine chinangwa chekubatana nevatungamiriri veindasitiri, vanogadzira zvinhu zvitsva, uye vane chekuita nechiitiko ichi chine mukurumbira pasi rose.
Musangano uyu uchapa Bioocus mukana wekutsvaga kushanda pamwe chete uye kubatana kunoenderana nebasa rayo rekukurumidzisa kugadzirwa kwemishonga yechizvarwa chinotevera yekurapa kenza ne Zvirwere zveAutoimmuneKuburikidza nehurukuro dzakasununguka uye kugovana ruzivo nemasayendisiti anotungamira, vanachiremba, uye nyanzvi dzeindasitiri, Bioocus inoda kuziva mikana mitsva yekutsvagisa pamwe chete, kushandira pamwe chete, uye kudyidzana kwebhizinesi.
PaIGC 2024, Bioocus ine chinangwa chekuongorora mabhizinesi matsva anoenderana netekinoroji dziri kubuda mumunda wekurapa kwemajini nemasero. Sezvo mamiriro e biotech achiramba achichinja nekukurumidza, Bioocus yakazvipira kukurudzira kushanda pamwe chete kunogona kuvhura mukana wese wekurapa kunoshamisa. Nekubatanidza kufambira mberi kwetekinoroji nehurongwa hwekutengeserana hunochinjika, kambani iyi inotsvaga kutungamira kuwanikwa kwesainzi uye kukura kwebhizinesi kunoenderera mberi.
Kuburikidza nekutora chikamu kwayo muchiitiko ichi chepasi rose, Bioocus inotarisira kutamba basa guru mukuumba remangwana rekurapa kwemajini nemasero, uku ichiumba hukama hwakasimba huchasundira miganhu yezvinogona kuitika mukurapa kwemazuva ano.